About Us
iCellate is a Swedish life science company founded in 2011 with its laboratory and office located in Stockholm. iCellate develops cancer diagnostic services across the cancer lifecycle, from hereditary cancer risk (GeneMate®) to early detection, treatment prediction and treatment monitoring (CellMate®). The technologies are based on research from the Karolinska Institute in collaboration with the Karolinska University Hospital.
Contacts
-
Iohn Ryott
COO
Industrivägen 1 171 48 Solna
+46707433479
iohn.ryott@icellate.se -
Pelle Redare
CEO
Industrivägen 1 171 48 Solna
+46708178828
iohn.ryott@icellate.se